Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media
Observational Study of the Rhinopharyngeal Carriage of Streptococcus Pneumoniae (Sp) in Infants With Acute Otitis Media (AOM)
1 other identifier
observational
3,293
1 country
35
Brief Summary
The aim of this study is to assess in France the impact of Prevenar on the possible evolution of the pneumococcal serotypes distribution and antibiotic resistance in NP samples of children with AOM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2005
Shorter than P25 for all trials
35 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 19, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2006
CompletedJune 29, 2010
June 1, 2010
9 months
September 13, 2005
June 27, 2010
Conditions
Keywords
Interventions
Eligibility Criteria
Screening, Cross-Sectional, Defined Population, Prospective Study
You may qualify if:
- Infants aged from 6 to 24 months
- Presenting with AOM (ear infection)
- Patients must not have received any antibiotic therapy within the past 7 days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (35)
Unknown Facility
Auch, 32000, France
Unknown Facility
Brest, 29200, France
Unknown Facility
Canne La Boca, 06150, France
Unknown Facility
Chambéry, 73000, France
Unknown Facility
Châlons-en-Champagne, 51000, France
Unknown Facility
Combs-la-Ville, 77380, France
Unknown Facility
Créteil, 94000, France
Unknown Facility
Draguignan, 83300, France
Unknown Facility
Essey-lès-Nancy, 54270, France
Unknown Facility
Fontenay-sous-Bois, 94120, France
Unknown Facility
Grenoble, 38000, France
Unknown Facility
Grigny, 91350, France
Unknown Facility
Lagny, 77400, France
Unknown Facility
Les Lilas, 93260, France
Unknown Facility
Les Ulis, 91940, France
Unknown Facility
Lyon, 96003, France
Unknown Facility
Marquette-lez-Lille, 59520, France
Unknown Facility
Marseille, 13013, France
Unknown Facility
Massy, 91300, France
Unknown Facility
Molsheim, 67120, France
Unknown Facility
Paris, 75006, France
Unknown Facility
Paris, 75007, France
Unknown Facility
Paris, 75015, France
Unknown Facility
Paris, 75020, France
Unknown Facility
Paris, 75116, France
Unknown Facility
Rouen, 76000, France
Unknown Facility
Saint-Brieuc, 22000, France
Unknown Facility
Saint-Maur-des-Fossés, 94100, France
Unknown Facility
Sélestat, 67600, France
Unknown Facility
Thionville, 57100, France
Unknown Facility
Toulouse, 31000, France
Unknown Facility
Tours, 37000, France
Unknown Facility
Vandœuvre-lès-Nancy, 54500, France
Unknown Facility
Vence, 06140, France
Unknown Facility
Villeneuve-lès-Avignon, 30400, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Medical Monitor
Wyeth is now a wholly owned subsidiary of Pfizer
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 19, 2005
Study Start
September 1, 2005
Primary Completion
June 1, 2006
Study Completion
June 1, 2006
Last Updated
June 29, 2010
Record last verified: 2010-06